Artificial Intelligence in Clinical Oncology: From Data to Digital Pathology and Treatment
American Society of Clinical Oncology Educational Book · 2023-05 · (43)
DOI: 10.1200/edbk_390084 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Society of Clinical Oncology Educational Book, 2023-05. Verfasst von Kirthika Senthil Kumar und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Design. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 88 Literaturangaben.
Abstract (Originalsprache)
Recently, a wide spectrum of artificial intelligence (AI)–based applications in the broader categories of digital pathology, biomarker development, and treatment have been explored. In the domain of digital pathology, these have included novel analytical strategies for realizing new information derived from standard histology to guide treatment selection and biomarker development to predict treatment selection and response. In therapeutics, these have included AI-driven drug target discovery, drug design and repurposing, combination regimen optimization, modulated dosing, and beyond. Given the continued advances that are emerging, it is important to develop workflows that seamlessly combine the various segments of AI innovation to comprehensively augment the diagnostic and interventional arsenal of the clinical oncology community. To overcome challenges that remain with regard to the ideation, validation, and deployment of AI in clinical oncology, recommendations toward bringing this workflow to fruition are also provided from clinical, engineering, implementation, and health care economics considerations. Ultimately, this work proposes frameworks that can potentially integrate these domains toward the sustainable adoption of practice-changing AI by the clinical oncology community to drive improved patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- The N.1 Institute for Health (N.1), National University of Singapore, Singapore.
- Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore.
- Department of Electronics, Informatics, and Bioengineering, Politecnico di Milano, Milan, Italy.
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
ORCID-Profile: Dean Ho
Zitieren
APA
Senthil Kumar, K., Miskovic, V., Blasiak, A., Sundar, R., Pedrocchi, A. L. G., Pearson, A. T., Prelaj, A., & Ho, D. (2023). Artificial Intelligence in Clinical Oncology: From Data to Digital Pathology and Treatment. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_390084
Vancouver
Senthil Kumar K, Miskovic V, Blasiak A, Sundar R, Pedrocchi ALG, Pearson AT, et al. Artificial Intelligence in Clinical Oncology: From Data to Digital Pathology and Treatment. American Society of Clinical Oncology Educational Book. 2023. doi:10.1200/edbk_390084
BibTeX
@article{SenthilKumar2023,
author = {Senthil Kumar, Kirthika and Miskovic, Vanja and Blasiak, Agata and Sundar, Raghav and Pedrocchi, Alessandra Laura Giulia and Pearson, Alexander T and Prelaj, Arsela and Ho, Dean},
title = {Artificial Intelligence in Clinical Oncology: From Data to Digital Pathology and Treatment},
journal = {American Society of Clinical Oncology Educational Book},
year = {2023},
number = {43},
doi = {10.1200/edbk_390084}
}
EUVIMED